Clinical Case Presentation Should Be In A Soap Format Same Soap Forma
Clinical case presentation should be in a SOAP format. Same SOAP format you use to submit your notes on Typhon. But you must make sure the information provided below is included or added for the purpose of this paper. It should be written in correct grammar, no APA but the references. References must be on APA format at the end of your papers corresponding to the citations throughout your paper.
An unusual case means a challenging case to you. From the soap you will use: Chief complaint and history of present disease. Exam and diagnostic tests (labs, images). Dx impression supported by signs and symptoms. Management as on soap I sent: meds, tests if any ordered, education, follow-up. Evidence-based rationale for treatment. Like aspirin is an antiplatelet use to and it’s reference. Epidemiological data with reference. For example, angina. Go to the CDC website and look for percent of populations affected, distribution with USA population.
Analysis of self-care and family issues related to diagnosis and treatment plan related to your Dx. Ex.: Patient is poor compliant with medication and no family support. First choice of antianginal treatment not used because lack of insurance coverage and use instead. Evaluate parameters to determine outcome. Use same as the short and long-term goals on our RN care plans but more treatment and prevention related.
Major lesson learned from the case and how it may affect your future practice. This analysis is your experience. Attached is the SOAP note template and information that can be used to do the soap note.
Paper For Above instruction
In this paper, I will present a challenging and unusual case of angina pectoris, formatted in a SOAP (Subjective, Objective, Assessment, Plan) note, incorporating comprehensive clinical, diagnostic, and psychosocial considerations. This structured approach aims to illustrate the complexity of diagnosis and management in atypical cardiovascular cases, emphasizing evidence-based practices, patient-centered care, and the integration of epidemiological data to inform treatment strategies.
Subjective
The patient, a 58-year-old male, presented with complaints of intermittent chest pain over the past two weeks. He described the pain as pressing, centrally located, and radiating to the left arm, with episodes lasting approximately 10 to 15 minutes. The pain was often precipitated by exertion and relieved by rest.
The patient reported associated symptoms of shortness of breath and mild dizziness but denied nausea, vomiting, or syncope. His medical history included hypertension, hyperlipidemia, and a 30-pack-year smoking history. He reports non-compliance with antihypertensive medications due to financial constraints and limited access to healthcare services. He lives alone and has minimal family support, which impacts his medication adherence and health management.
Objective
Vital signs revealed blood pressure of 148/90 mm Hg, heart rate of 88 bpm, respiration rate of 16 per minute, and oxygen saturation of 97% on room air. Physical examination showed no chest wall tenderness, normal heart sounds with no murmurs, and clear lung fields. Cardiac auscultation revealed regular rhythm without abnormal sounds. Laboratory tests included fasting lipid profile showing elevated LDL cholesterol at 160 mg/dL, HDL at 40 mg/dL, and triglycerides at 180 mg/dL. An EKG displayed normal sinus rhythm with occasional nonspecific ST-T wave changes. A stress test was positive for ischemic changes, and an echocardiogram revealed preserved left ventricular function with mild anterior wall hypokinesia. Coronary angiography was indicated but not yet performed due to financial limitations.
Assessment
The clinical presentation and diagnostic findings support a diagnosis of stable angina pectoris, likely due to atherosclerotic coronary artery disease. The patient's risk factors—hypertension, hyperlipidemia, smoking, and sedentary lifestyle—contribute to the development of coronary atherosclerosis. The positive stress test and echocardiographic findings reinforce the ischemic nature of his chest pain. Psychosocial factors, including medication non-compliance and limited social support, pose challenges to effective management.
Plan
Pharmacologic management included initiating low-dose aspirin (81 mg daily) as an antiplatelet agent to reduce the risk of myocardial infarction, supported by evidence showing its efficacy in secondary prevention of cardiovascular events (Antithrombotic Trialists' Collaboration, 2002). Due to his financial constraints, alternative medications such as nitrates for symptom relief were prescribed, along with a statin (atorvastatin 20 mg daily) to address dyslipidemia, in line with guidelines recommending statins for primary prevention in high-risk patients (Grundy et al., 2019). Blood pressure management was optimized with ACE inhibitors, considering their benefits in reducing cardiovascular events (Whelton et al., 2018).
Patient education emphasized smoking cessation, dietary modifications such as reduced saturated fat intake, and engaging in regular physical activity. The importance of medication adherence was reinforced, and follow-up was scheduled to assess symptom control and medication compliance.
Further diagnostic testing, including coronary angiography, was recommended but deferred until financial issues could be addressed. The patient was advised to seek assistance through community resources for urgent care if symptoms worsen. Psychosocial support was discussed, and the patient was referred to social services to improve medication adherence and explore assistance programs.
The evidence-based rationale for this comprehensive management plan revolves around reducing myocardial oxygen demand, preventing thrombotic events, and controlling modifiable risk factors.
Aspirin’s antiplatelet effect helps prevent clot formation (Antithrombotic Trialists' Collaboration, 2002). Statin therapy reduces LDL levels and stabilizes plaque, lowering the risk of acute coronary syndromes (Grundy et al., 2019). Smoking cessation significantly decreases the progression of atherosclerosis and improves overall prognosis (U.S. Department of Health and Human Services, 2014). Lifestyle modifications complement pharmacotherapy, emphasizing preventive cardiology principles.
Self-Care and Family Issues
The patient’s limited social support and economic constraints significantly impact his ability to adhere to treatment and lifestyle modifications. Non-compliance with medications due to cost and lack of family oversight presents a barrier to effective disease management. Family involvement is crucial for reinforcing health behaviors and ensuring medication adherence. Post-diagnosis, the patient expressed difficulty in understanding the importance of medication and lifestyle changes, indicating a need for targeted education and support systems. Addressing these psychosocial factors through community and social services can improve compliance and outcomes.
Evaluation of Parameters and Outcomes
Parameters such as symptom frequency, blood pressure, lipid profile, and adherence levels will be monitored regularly. Short-term goals include symptom control, blood pressure normalization, and medication adherence within 4-6 weeks. Long-term goals focus on reducing cardiovascular risk factors to prevent future ischemic events, with ongoing lifestyle modifications and medication compliance reinforced through follow-up visits. Success will be measured through patient-reported symptom relief, improved lipid levels, and controlled blood pressure, in addition to reduced hospitalizations for cardiac events.